Facebook
X
LinkedIn
Forward(ACCREDITATION SAMPLE) MEDISCA Australia | Functional and Personalised Hormone Restoration Therapy: The Fundamentals
MEDISCA Australia
Functional and Personalised Hormone Restoration Therapy: The Fundamentals
The roles that hormones play in body physiology and pathology are intricate, complex, and multifaceted. These communicatory molecules are central players in the maintenance and regulation of multi-organ systems and functions, including digestion, metabolism, sexual reproduction, lactation, growth, development, sleep, and stress, among much more. Hormonal actions are specific as well as interactive and diverse. With their critical roles in whole-body homeostatic maintenance, even the most subtle deviation in hormonal levels has the potential to produce vast multi-system changes that can clinically emerge as a variety of symptoms. To further complex the matter of hormonal systems, there exists substantial variations in individual hormone levels required for maintaining individual set-points. What may be normal for one, may be abnormal for another.
In this educational activity, participants will gain an appreciation for the individuality of hormonal systems and the need for personalised medicine tailored to an individual’s unique clinical profile. This course emphasises an integrative and evidence-based toward medicine that involves applying empirical, clinical, and case study findings that outlines the importance of addressing the underlying cause of disease. Participants will learn about the need for staying current with scientific advancements and the growing demand for patient-tailored solutions for hormone restoration. Opportunities for customization, including opportunities in pharmaceutical compounding, will be discussed for various hormone-related conditions, including:
- Premenstrual Syndrome
- Perimenopause
- Menopause
- Thyroid Dysfunctions
- Adrenal Dysfunctions
- Male and Female Sexual Dysfunction
- Polycystic Ovarian Syndrome
- Metabolic Syndrome
- Insulin Resistance
This program will allow healthcare providers from various backgrounds, pharmacists, physicians, and naturopathic doctors among others, with the unique opportunity to collaborate together to produce a patient-centered treatment regimen based on concepts and evidence discussed in this activity. Participants will be presented with clinical evidence on the benefits and risks of hormone restoration therapy and how it can be optimally applied. All course material will be put to practice through interactive case studies that involve assessing patient clinical profiles and devising appropriate and customised therapeutic solutions.
Intended audience
Physicians, pharmacists and nurse practitioners engaged in prescription hormone practice.
This learning activity has received financial support from MEDISCA in the form of an educational grant.
Saturday-Sunday, 8am-5pm
Doors open from 7:30am
DAY 1 | ||
8:00AM – 8:15AM | Orientation/Introduction | |
8:15AM – 9:30AM | SECTION 1 : Fundamental Principals and Rules of Engagement | Restoration and Balance |
Relative Versus Absolute | ||
Balance and Relative Sensitivity | ||
Free versus Bound | ||
Up and Down Regulation | ||
Additive, Synergistic, and Antagonistic Activity | ||
Pharmacokinetic versus Pharmacodynamic Balance | ||
Cyclic versus Continuous Dosing | ||
Routes of Delivery and Delivery Systems | ||
Monitoring Frequency and Therapeutic Intent | ||
Minimum Dose for Maximum Effect | ||
Philosophical Guideline | ||
9:30AM – 10:45AM | SECTION 2 : Hormones and Hormone System Functions
| When Harry met Sally |
Hierarchical Function and the Hormone Cascade | ||
Influence of Exogenous Factors and Disease | ||
The Endocrine Organs | ||
The Hypothalamic-Pituitary-Gonadal Axis | ||
Menstrual Cycle Phases | ||
Menstrual Cycle Hormones | ||
Abnormal Menstrual Cycle | ||
Sally's Daughter Brittany | ||
Sally in Perimenopause | ||
Specific Symptoms of Hormone Imbalances in Females | ||
10:45AM – 11:05AM | Morning Tea | |
11:05AM – 11:45AM | SECTION 3 : Evaluating the Risk of Female Hormone Restoration
| Sally and Susie in a State of Disrepair |
Synthetic versus Bioidentical | ||
Oral versus Transdermal | ||
Estrogen Types, Binding, and Dosing | ||
Androgen Therapy | ||
North American Menopause Society | ||
11:45AM – 12:30PM | SECTION 4 : Subjective and Objective Testing
| Depression and Symptom Bias |
Assessment Algorithm | ||
Case Assessment Design and Instructions | ||
Hormone Testing | ||
Hormone Testing and Route of Delivery | ||
Caution regarding Normative Databases | ||
Pausing Medication for Testing | ||
12:30PM – 1:15PM | Lunch | |
1:15PM – 1:35PM | SECTION 5 : Inter-Hormone Relationships |
|
1:35PM – 2:45PM | SECTION 6 : Adrenal Function and Dysfunction | Sally has succumbed to Fatigue |
General Adaption Model | ||
Cortisol | ||
Specific Symptoms of Hormone Imbalances in Females | ||
Progesterone Steal | ||
Low Androgen in Females | ||
High Androgen in Females | ||
Adrenal Hypofunction | ||
2:45PM – 3:05PM | Afternoon Tea | |
3:05PM – 3:50PM | SECTION 7: Adjunct Nutraceutical Therapy | Nutraceuticals |
Quality Concerns | ||
Nutraceutical Functions and Recommended Dosages | ||
3:50PM – 5:00PM | SECTION 8: Special Considerations Related to Treatment Protocols | Life Cycle Related Considerations |
Non-Ovulation Premenopausal Circumstance Considerations | ||
Pregnancy and Lactation Related Considerations | ||
Cancer Risk Related Considerations | ||
Lifestyle Related Considerations | ||
DAY 2 | ||
8:00AM – 9:30AM | SECTION 9 : Treatment Protocols for Male Hypogonadism and Male Sexual Dysfunction
| Treatment Protocol for Premenstrual Syndrome |
Treatment Protocol for Perimenopause | ||
Treatment Protocol for Natural Menopause | ||
Treatment Protocol for Surgical Menopause | ||
Treatment Protocol: Bi-Est Strength & Percentages | ||
Inter-Hormone Relationships and Ovarian Function | ||
Case Study 1 | ||
9:30AM – 11:00AM | SECTION 10 : Male Hypogonadism and Sexual Dysfunction
| The Challenge |
Specific Symptoms of Hormone Imbalances in Males | ||
Treatment Protocol for Andropause | ||
Treatment Protocol for Hypogonadism | ||
Treatment Protocol for Erectile Dysfunction | ||
Case Study 2 | ||
11:00AM – 11:20AM | Morning Tea | |
11:20AM – 12:20PM | Section 11 : Thyroid Function and Dysfunction | Sally – Thyroid or Adrenal Dysfunction |
The Hypothalamic-Pituitary-Thyroid (HPT) Axis | ||
Thyroid Hormone Metabolism | ||
Inter-Hormone Relationships and Thyroid Function | ||
Thyroid Dysfunctions | ||
Case Study 3 | ||
12:20PM – 1:00PM | SECTION 12 : Female Sexual Dysfunction
| Harry and Sally |
Vulvar and Vaginal Atrophy | ||
Vulvodynia | ||
Case Study 4 | ||
1:00PM – 1:45PM | Lunch | |
1:45PM – 3:00PM | SECTION 13 : Strategies for Treatment Modification
| Detoxification from Excessive Hormone Therapy |
End of Treatment Strategy - Female | ||
End of Treatment Strategy - Male | ||
Harry and Sally in their Later Years | ||
Case Study 5.1 | ||
Case Study 5.2 | ||
3:00PM – 3:20PM | Afternoon Tea | |
3:20PM – 4:00PM | SECTION 14 : Route of Delivery, Dosage Form and Delivery System | Route of Delivery |
Dosage Form | ||
Delivery System | ||
Delivery Device | ||
Special Considerations | ||
4:00PM – 5:00PM | SECTION 15 : PCOS, Metabolic Syndrome, and Insulin Resistance | Polycystic Ovary Syndrome |
Metabolic Syndrome | ||
Case Study 6 | ||
Travel information
Address: Unit 2, 5-9 Ricketty Street, Mascot NSW
How to get there:
Train: Closest station is Mascot, then 10 minute walk
Car: View map and directions - free parking available
Sydney Domestic/International Airport: 15 minute Uber or Taxi
If you need any assistance on the training days, please call 0423 698 856
The closest hotel we recommend is Meriton Mascot Central (7 minutes walking distance) https://www.meritonsuites.com.au/our-hotels/nsw/airport/mascot-central/
You can use our discount code if you book online, input Reservation Code ‘22000076’
Otherwise there is also: Meriton Coward St, Adina Apartments Sydney Airport, Holiday Inn Sydney Airport, Pullman Sydney Airport.
TARA D. SCOTT, MD, FACOG, FAAFM, ABOIM, NCMP Disclosure: None |
|
Dr. Tara Scott graduated from Northeast Ohio University College of Medicine and completed her residency with Summa Health Systems at Akron City Hospital in Ohio. She recently retired from OB/GYN after almost 20 years to focus on functional and integrative medicine. She is a Clinical Associate Professor at Northeast Ohio Medical University, where she teaches residents and is involved in clinical research.
Dr. Scott is a certified menopause practitioner with the North American Menopause Society and a fellow of the American College of Obstetrics and Gynecology. She first became involved with hormone and integrative medicine while practicing as an OB/GYN. Her empathy for patients experiencing hormone-related issues led her to become trained as an advanced fellow and certified by the American Academy of Anti-Aging Medicine. The evidence-based practices she employed helped many patients conquer chronic wellness issues. She then started Revitalize Medical Group, where she serves as the Chief Medical Officer. In 2016, she obtained an additional board certification in Integrative Medicine. Recently, Dr. Scott was appointed as Medical Director for Summa Health in Akron, Ohio, where she will develop and run an Integrative Medicine program. Dr. Scott is passionate about educating the medical community on the advances in evidence-based hormone therapy. She lectures around the community to raise awareness about wellness and hormone balance.
LISA BATES, PHARMD Disclosure: None |
|
Dr. Lisa Bates is a pharmacist, perimenopause specialist, and educator with over 15 years of clinical, academic, and leadership experience. She earned her Doctor of Pharmacy degree from Midwestern University College of Pharmacy-Glendale in 2008 and completed a PGY-1 Ambulatory Care Pharmacy Residency at Palm Beach Atlantic University.
Dr. Bates is the Founder and CEO of Empower Rx, where she serves as HRT consultant and women’s health coach, specializing in HRT, midlife nutrition, and nervous system regulation. She consults with healthcare providers on complex HRT cases while also working directly with patients to implement personalized lifestyle, nutrition, and hormone optimization strategies. Her work centers on supporting women through perimenopause by addressing the dynamic interplay between hormones and the nervous system. She is known for translating complex clinical concepts into practical, actionable strategies for both healthcare professionals and patients.
Prior to this, she served as Pharmacist-in-Charge at one of the nation’s top compounding pharmacies. Her background in compounding provides a strong foundation in HRT formulations, safety, and regulatory considerations.
Dr. Bates has extensive experience in sterile and non-sterile compounding, including USP <795>, <797>, and <800> standards, as well as PCAB, state and federal regulations. She developed an ASHP-accredited compounding residency program and has educated pharmacy students, clinicians, and healthcare teams through both live and virtual platforms worldwide.
Dr. Bates is a dynamic speaker and educator, delivering evidence-based education on hormone health, compounding, and patient-centered care. She is committed to equipping practitioners and patients with the knowledge and tools needed to support optimal health outcomes
Completion requirements:
Attend in full, complete learning assessments, and complete the activity evaluation.
For Pharmacists:
This program has been submitted for pharmacist CPD accreditation.
Learning Outcomes:
- Review the unique set of rules applicable to customised hormone restoration therapy.
- Describe the hormone cascade, its neurobiological communication network, effects of exogenous and endogenous factors on the cascade, and impact on endocrine and neighboring digestive and immune systems.
- Evaluate the risks and benefits of hormone restoration therapy
- Compare serum, urine, and saliva testing approaches as a quantitative, objective means to assess hormone levels in addition to a qualitative, subjective approach (patient symptom evaluation)
- Discuss physiological and dysfunctional hormone signaling of the adrenal, thyroid, and male/female reproductive systems, and their associated treatment protocols, including the role of adjunct nutraceutical therapy
- Evaluate comprehensive patient assessment chart data to classify patient hormone abnormalities underlying different hormone dysfunctional conditions
- Identify therapeutic alternatives by way of hormone therapy, adjunct nutraceutical therapy, and patient-specific treatment considerations across different hormone dysfunctional conditions based on classification of hormone abnormalities of patient assessments
- Discuss the various routes of delivery, delivery systems, dosage forms, and dispensing mechanisms used in hormone therapy, adjunct therapy, nutraceutical supplementation, and specific aspects of lifestyle management; and monitor patient responses through quantitative and qualitative
Pharmacist Competencies: 1.1, 1.2, 1.3, 1.4, 1.5, 3.1, 3.2, 3.4, 3.5
For Physicians:
This Activity may be eligible for self-directed CPD credits (Category 1: Educational Activities)
Price
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation. In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date. This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY – AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.